FORT LEE, N.J., Oct. 25 /PRNewswire-FirstCall/ -- Alpharma Inc. announced that the company will release its third quarter 2006 earnings after the market close on Monday, October 30, 2006. Alpharma management, including the company’s newly appointed Chief Executive Officer, Dean Mitchell, will conduct a conference call / webcast on Tuesday, October 31, 2006 beginning at 8:30 AM Eastern Standard Time to discuss its third quarter results.
The call will be open to all interested parties and may be accessed by using the following information:
CONFERENCE CALL ACCESS Domestic Dial In: (800) 374-0147 International Dial In: (706) 634-5431 Conference Call ID: 8803484
Investors can access the call in a “listen only” mode via the Internet at http://www.streetevents.com.
In addition, for those unable to participate at the time of the call, a rebroadcast will be available following the call from Tuesday, October 31, 2006 at 12:00 PM Eastern Standard Time until Tuesday, November 7, 2006 at midnight. The rebroadcast may be accessed on the Internet at http://www.streetevents.com or by telephone using the following information:
REBROADCAST ACCESS Domestic Dial In: (800) 642-1687 International Dial In: (706) 645-9291 Participant Code: 8803484
Alpharma Inc. is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 60 countries. Alpharma has a growing branded franchise in the chronic pain market with its morphine-based extended release KADIAN(R) product. In addition, Alpharma is among the world’s leading producers of several specialty pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.
Alpharma Inc.
CONTACT: Kathleen Makrakis - VP, Investor Relations, +1-201-228-5085,kathleen.makrakis@alpharma.com
Web site: http://www.alpharma.com//
